Doppl provides a toxicity screening service using an established model of human healthy gastro-intestinal organoids.
Get started ↗
Doppl provides a screening of epithelial fluid transport using an established model of human healthy gastro-intestinal organoids.
Get started ↗
Doppl develops customized organoid lines that accurately model your tissues or diseases of interest.
Get started ↗Oncology
Deepen your insights into your oncology programs with our models of various indications.
Learn more ↗Inflammatory diseases
Define the optimal therapeutic approach for your inflammatory diseases with our panel of gastrointestinal organoid models
Learn more ↗Rare diseases
Explore the landscape of therapeutic approaches using our advanced screening platform.
Learn more ↗Immuno-oncology
Choose the right immunotherapy approach using our standardized tumor-immune cell co-culture workflow
Learn more ↗ADME-Tox
Investigate the ADME-Tox profile of your compounds of interest on our portfolio of various healthy organoid models.
Learn more ↗
Jeroen Van den Oever
Founder & Chief Executive Officer
Nathalie Brandenberg
Founder & Chief Scientific Officer
Aline Roch
Head of R&D
Francesco Piraino
Head of Product Management
Marine Meyer
Product Manager
Elisa Heinzelmann
Associate Product Manager
Victor Anstett
Product Development Lead
Mariana Costa
Senior Scientist
Camilla Ceroni
Senior Scientist
.jpg)
Pascaline Sirugue
Junior Scientist
Katia Antoniello
Laboratory Manager
Ogier Bouvier
Software Engineer
Olivier Naret
Senior Bioinformatics Lead
Juliane Dervaux
Bioinformatics Engineer
Franck Lesage
Head of Software Engineering
Virginie Garnier
Junior Marketing Specialist
Alice Pellegrino
Research Associate
.jpg){kind=logo}
